Back to companies
PORTFOLIO
Oculis
Oculis focuses on ophthalmic drugs and topical eye drug formulations. Oculis has developed a formulation technology consisting of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug formulation where diseases of the posterior part of the eye can be treated with a simple topical application (i.e., eye drops) instead of injections or implants.
Milestones
Founded: 2017 Invested: 2020
Leadership Team
Riad Sherif
HQ
Lausanne, Switzerland
Earlybird Deal Team

OUR PORTFOLIO
SIMILAR COMPANIES
Meet the companies we’ve backed on their way to creating groundbreaking change.
WE INVEST BECAUSE
WE BELIEVE
Got an idea that could change the world? If you're an early-stage founder with big ambitions, we'd love to hear from you.







